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Objectives: Tinnitus is a very common symptom in patients with hear-
ing loss. Several studies have confirmed that hearing restoration using 
hearing aids or cochlear implants (CIs) has a suppressive effect on tin-
nitus in users. The aim of this study was to analyze the effect of other 
hearing restoration devices, specifically the middle ear implant (MEI), on 
changes in tinnitus severity.
Design: From 2012 to October 2014, 11 adults with tinnitus and hearing loss 
underwent MEI surgery. Pure-tone audiometry, tinnitus handicap inventory 
(THI), and visual analog scale scores for loudness, awareness, and annoy-
ance and psychosocial instruments were measured before, immediately 
after, and 6 months after surgery. Changes in hearing thresholds and THI 
scores were analyzed and compared with those of 16 CI recipients.
Results: In both MEI and CI groups, significant improvements in tin-
nitus were found after the surgery. The THI scores improved in 91% of 
patients in the MEI group and in 56% of those in the CI group. Visual 
analog scale scores and psychosocial scale scores also decreased after 
surgery, but there were no statistical differences between the groups.
Conclusions: The results indicate that the MEI may be as beneficial as 
the CI in relieving tinnitus in subjects with unilateral tinnitus accompa-
nying hearing loss. Furthermore, this improvement may manifest as 
hearing restoration or habituation rather than a direct electrical nerve 
stimulation, which was previously considered as the main mechanism 
underlying tinnitus suppression by auditory implants.
Key words: Cochlear implant, Middle ear implant, Tinnitus, Tinnitus 
handicap inventory.
(Ear & Hearing 2015;36;705–709)
INTRODUCTION
Tinnitus is a disturbing sensation that affects between 10% 
and 15% of the population; of those affected, 20% experience 
a significant decrease in quality of life as a result of tinnitus 
(Axelsson & Ringdahl 1989). Previous studies have revealed 
no compelling evidence suggesting the efficacy of any pharma-
cologic agent in the treatment of tinnitus (Patterson & Balough 
2006). The inadvertent therapeutic effects of cochlear implan-
tation on previously existing tinnitus had been noted in initial 
studies on cochlear implants (CIs; Vallés-Varela et al. 2013). 
Many authors have reported that existing tinnitus improved by 
up to 93% in patients after cochlear implantation (Ito 1997; 
Tyler 1995). The postulated effect of the CI on tinnitus was that 
by restoring the auditory input, the patient could recover the 
tonotopic reorganization of the auditory pathway after implant 
programming (Vermeire et al. 2008), and a masking effect 
could be produced (Culling et al. 2012). Recently, the middle 
ear implant (MEI) has become an alternative to conventional 
hearing devices for patients with moderate to severe sensori-
neural hearing loss. MEIs can also restore auditory input, and 
we hypothesized that MEIs show a therapeutic effect on existing 
tinnitus in patients with moderate to severe hearing loss.
We investigated the effect of MEIs in patients who experi-
enced tinnitus with moderate to severe hearing losses compared 
with treatment with a CI.
MATERIALS AND METHODS
The assessment was carried out on patients with ipsilateral 
tinnitus who received unilateral MEIs from 2012 to 2014. These 
patients were then compared with patients who had tinnitus and 
received CIs. Patients in both groups experienced sensorineural 
hearing loss and asymmetrical hearing loss, and they also had 
unilateral tinnitus. Although they were primarily annoyed with 
the hearing loss, they were also aware of the tinnitus and wanted 
to get rid of the discomfort caused by it.
We used the following inclusion criteria: age greater than 
15 years; a history of stable unilateral tinnitus for over 2 years; 
and the absence of a response to any previous treatment. The 
following conditions were considered as exclusion criteria: the 
existence of possible organic causes for tinnitus, presence of 
cochlear nerve aplasia or dysplasia, retrocochlear regrowth at 
any stage of evolution, and a history of implantations with prob-
lematic results.
Every patient of the MEI group (MEI group, n = 11) received 
the Vibrant Soundbridge (MED-EL, Innsbruck, Austria), while 
the implants used in the CI group (CI group, n = 16) varied 
among the CI 24RE, CI422, and Medel-Sonata models accord-
ing to the patient’s cochlear status.
To assess pre- and postoperative tinnitus severity, we per-
formed several interviews in addition to obtaining the initial 
medical history. The first interview was carried out preop-
eratively with a tinnitus handicap inventory (THI proposed by 
McCombe et al.), visual analogue scale (VAS for loudness, 
awareness, and annoyance, with ratings from 0 to 10), Beck 
depression inventory (BDI), and Brief Encounter Psychosocial 
Instrument (BEPSI). The subsequent interviews were conducted 
immediately after and 6 months after implantation and involved 
the same tests and full compliance. Without any tinnitus retrain-
ing therapy and any further treatments for tinnitus during the 
periods, all patients were followed up. We supposed that the tin-
nitus reduction effect occurred as a masker. We characterized an 
“improvement” as a decrease of over 20% in postoperative THI 
scores compared with the preoperative THI scores (Khedr et al. 
2008) or a decrease of more than 2 THI score grades according 
to McCombe’s (McCombe et al. 2001) classification (Table 1). 
We also defined an improvement in VAS, BDI, and BEPSI as a 
decrease of more than 20% in postoperative scores compared 
with the preoperative scores.
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Power analysis was based on the differences in tinnitus 
improvement between patients with CI activated or deactivated, 
as described by Van de Heyning et al. (2008). We hypothesized 
that if the mean THI in the MEI group was not 25% higher 
than that in the CI group with a power of 0.80 and a two-sided 
value of p < 0.05, 12 individuals would have to be included for 
both groups. Results were analyzed using the Fisher exact test 
and the Mann-Whitney-Wilcoxon test. The level of significance 
was set at p < 0.05. A bivariate correlation analysis was used 
to analyze the correlation between the THI and the pure-tone 
audiometry (PTA) results. Statistical analyses were performed 
using SPSS v21.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
In patients with an MEI, the therapeutic effects on tinnitus 
were encouraging. The initial mean THI score was 43.82 ± 31.51, 
and 6 months after surgery, the mean THI score was 24 ± 19.09 
(p = 0.001). Of the 11 patients, 10 (91%) showed more than 
20% improvement in the THI score and 6 (54%) showed more 
than two grades of improvement in the THI score according to 
McCombe’s classification.
We compared the therapeutic effects of MEIs on tinnitus with 
those of CIs. In both MEI and CI groups, there were no signifi-
cant differences in the preoperative clinical characteristics sur-
veyed except for hearing thresholds (Table 2). The initial mean 
THI scores for the MEI and CI groups were 43.82 ± 31.51 and 
46.46 ± 32.96, respectively (p = 0.097). The THI scores mark-
edly improved 6 months after surgery in both groups (Fig. 1). 
The characteristics of tinnitus between both groups were similar 
(Table 3), but the maskability for tinnitus, which was evaluated 
after using hearing aids over 3 months, was better in the MEI group 
than that in the CI group (p = 0.02). Comparing the differences 
between the pre- and the postoperative THI scores in the MEI and 
CI groups, the improvement in the MEI group was bigger than that 
in the CI group but not significantly different (p = 0.097). Consid-
ering the 20% decrease in score criteria, the MEI group showed a 
higher improvement rate (91%) than the CI group (56%), but no 
significant difference was observed (Table 3; p = 0.284). Accord-
ing to McCombe’s classification, the MEI group (54%) and the CI 
group (56%) both showed similar improvement rates in THI grades 
(Table 4). However, there was no significant difference in the grade 
change distributions between the groups (p = 0.118).
The patients in each group were also questioned on how 
the tinnitus affected their lifestyle and emotions in terms of 
loudness, awareness, and annoyance using a symptom rating 
scale based on a VAS self-reported questionnaire (Fig. 2A), 
as well as BDI and BEPSI (Fig. 2B). In the MEI group, the 
improvement in loudness, annoyance, and awareness on the 
VAS assessments was 55%, 55%, and 45%, respectively 
(Table 5). Similarly, in the CI group, the improvements were 
TABLE 1. Classification of the tinnitus handicap inventory (THI) 
scores according to McCombe et al. (2001)
Total 
Score Indication Grade
0–16 Slight (only heard in quiet environments) Grade 1
18–36 Mild (easily masked by environmental sounds  
and easily forgotten with activities)
Grade 2
38–56 Moderate (noticed in the presence of  
ackground noise, although daily activities  
can still be performed)
Grade 3
58–76 Severe (almost always heard, leads to  
disturbed sleep patterns and can interfere  
with daily activities)
Grade 4
78–100 Catastrophic (always heard, disturbed sleep 
patterns, difficulty with any activities)
Grade 5
TABLE 2. The demographic and clinical characteristics of the 
study populations
Variables
MEI Group  
(n = 11)
CI Group  
(n = 16) p Value
Age (yr) 58.45 ± 6.44 51.94 ± 13.73 0.112
Sex (male:female) 6:5 10:6 0.302
Implant site (right: left) 5:6 8:8 0.791
Pre-PTA 57.0 ± 15.64 94.63 ± 23.24 <0.001
Post-PTA 38.55 ± 8.86 39.77 ± 10.54 0.747
Time of tinnitus 6.73 ± 7.77 8.43 ± 7.64 0.549
Pre-THI scores 43.82 ± 31.51 46.46 ± 32.96 0.097
A p value < 0.05 value was set as the significance level, and significant differences between 
groups are shown in bold.
ME, Middle ear implant; PTA, pure-tone audiometry; THI, tinnitus handicap inventory.
Fig. 1. The improvements in tinnitus handicap inventory (THI) scores at 6 
months after the surgery in both middle ear implant (MEI) and cochlear 
implant (CI) groups (p = 0.001, p = 0.042, respectively). There is no signifi-
cant difference between the MEI and the CI groups (p = 0.097).





(n = 16) p Value
Character 0.41
  Buzz/murmur 6 (55%) 7 (43%)
  Pure tone 2 (18%) 3 (19%)
  Other 1 (9%) 2 (13%)
  Missing 2 (18%) 4 (25%)
Type of tinnitus 0.66
  Continuous 4 (36%) 6 (37%)
  Variable 4 (36%) 4 (25%)
  Missing 3 (27%) 6 (37%)
Maskability* 0.02
  Yes 4 (36%) 1 (7%)
  No 1 (9%) 12 (74%)
  Missing 6 (55%) 3 (19%)
*Maskability for tinnitus evaluated after using hearing aid over 3 months before the surgery. 
A p value <0.05 value was set as the significance level, and significant differences between 
groups are shown in bold.
MEI, Middle ear implant.
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63% in loudness, 69% in annoyance, and 44% in awareness. 
There was also no statistically significant difference between 
the MEI and the CI groups in terms of improvement and no 
changes or worsening in the symptoms assessed in the VAS 
self-reported questionnaire. The BDI and BEPSI were used 
to assess the relationship between the type of implant and the 
psychological disorders, such as stress, anxiety, and depres-
sion. In the MEI group, the improvements were 73% on the 
BDI and 55% on the BEPSI. In the CI group, the improve-
ments were 88% on the BDI and 62% on the BEPSI. As 
expected, the differences between the MEI and the CI groups 
in both BDI and BEPSI were not statistically significant.
The correlation between the variability in THI scores and the 
variability in PTA was not significant (Fig. 3); the correlation 
coefficient was 0.133 (p = 0.696) in the MEI group and 0.246 
(p = 0.359) in the CI group.
DISCUSSION
We compared the effects of an MEI on tinnitus with those 
of a CI. The MEI decreased the severity of tinnitus in many 
patients, and there was no significant difference in THI score 
variability between patients in the MEI and CI groups. We sug-
gest that the degree of recovery in terms of hearing threshold is 
not correlated with tinnitus improvement and that slight ampli-
fications of sound can improve tinnitus. The recovered hearing 
threshold after the surgery does affect the severity of tinnitus, 
regardless of the difference between the pre- and postoperative 
hearing threshold. The results indicate that MEIs may be as ben-
eficial as CIs in subjects with unilateral tinnitus accompanying 
moderate to severe hearing loss.
In our study, preoperative thresholds of PTA were sig-
nificantly different (57.0 ± 15.64 in the MEI group versus 
94.63 ± 23.24 in the CI group). Because the indications for 
the operation were different, we performed the MEI surgery 
on patients with moderate to severe sensorineural hearing loss 
(SNHL) and CI surgery on patients with severe to profound 
SNHL. However, despite the differences in hearing thresholds, 
both severity and duration of tinnitus before the surgery were 
not significantly different between the groups (p > 0.05).
Hearing aid technology has improved markedly over the past 
3 decades, offering ever-evolving device options for patients 
seeking to overcome their hearing deficits. MEIs provide an 
alternative to conventional hearing aids for patients who experi-
ence untoward feedback, the occlusion effect, or difficult fitting. 
Furthermore, as MEIs offer an effective method of rehabilitat-
ing moderate to severe SNHL, the use of MEIs may become an 
important treatment for patients with hearing loss (Colletti et 
al. 2006; Baumgartner et al. 2010). As hearing loss is related to 
tinnitus occurrence, we suggest that MEIs could be effective in 
patients who have moderate to severe hearing loss accompanied 
by tinnitus. To our knowledge, there has been no evidence of the 
effect of MEI on tinnitus before our study.
Many authors have pointed out improvements in tinnitus 
after cochlear implantation, with improvements reported in 
40% to 93% of implanted patients (Tyler 1995; Ito 1997). 
Perhaps the most notable aspect of the influence of the CIs on 
tinnitus is the discussion about the physiopathology of tinnitus 
itself. Vermeire et al. suggested that tonotopic reorganization 
of the cochlea, auditory pathway, and the cortex itself occurs 
after implant programming and that the auditory infrastruc-
ture consequently adapts to the new situation of frequencies 
(Vermeire et al. 2008). Thus, cochlear implantation may pro-
duce a masking effect on the existing tinnitus. In contrast, 
there are no known pathophysiologic accounts pertaining to 
the effects of MEIs for tinnitus. However, considering the 
principles underlying MEIs and hearing aids, the positive 
effect of MEIs on tinnitus could have occurred like in the 
case of hearing aids by: (1) reducing the attention toward 
TABLE 4. The THI score and grade changes (final THI–start THI) 
for patients in the MEI and the CI groups
Variables MEI Group CI Group p Value
THI score 
changes
Improved 10 (91%) 9 (56%) 0.284*
Unchanged 0 (0%) 4 (25%)
Worsened 1 (9%) 3 (19%)
THI grade 
changes
Improved 6 (55%) 9 (56%) 0.118*
Unchanged 4 (36%) 4 (25%)
Worsened 1 (9%) 3 (19%)
*Fisher exact test.
MEI, Middle ear implant; THI, tinnitus handicap inventory.
Fig. 2. The changes on symptom rating scales based on a visual analog scale (VAS) self-reported style questionnaire (A), as well as Beck depression inventory 
(BDI) and Brief Encounter Psychosocial Instrument (BEPSI) (B) at 6 months after the surgery in the middle ear implant (MEI) and cochlear implant (CI) groups.
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hearing loss (Newman 1999); (2) complete or partial mask-
ing of tinnitus by amplified noise/instrumental noise (Del 
Bo & Ambrosetti 2007); (3) counseling associated with 
the material (Searchfield 2006); and (4) reduction of cen-
tral gain by increasing auditory nerve activity (Moffat et 
al. 2009). These are consistent with a basic understanding 
of the Jastreboff model (Sheldrake & Jastreboff 2004). The 
maskability of hearing aids before the MEI surgery showed 
a greater percentage of improvement than that in CI (36% 
versus 7%). The results from the present study suggest that 
restoring the normal sensory input could be a more funda-
mental and physiological solution for the treatment of tin-
nitus after middle ear implantation. Without stimulating the 
nerve directly, only the amplification of sound and the res-
toration of serviceable hearing may decrease the severity of 
tinnitus and the reactions resulting from the limbic and auto-
nomic nervous system (Hazell & Jastreboff 1990).
To treat tinnitus, objective measurement of the severity of 
tinnitus is important (Henry et al. 2014). However, a lack of 
objective measurement methods for tinnitus can complicate 
studies on the condition. Therefore, we compared several 
proven tests for tinnitus such as the VAS system for subjec-
tive symptoms, BDI and BEPSI, as well as THI. The VAS 
improvements in loudness, awareness, and annoyance of tin-
nitus showed similar rates of occurrence in both groups. The 
results of this study concur with those of a study supported by 
the Tinnitus Research Initiative (TRI) and Med-El that investi-
gated the effects of an MEI and showed that five patients with 
severe tinnitus and high-frequency hearing loss achieved relief 
of their tinnitus after implantation (Biesinger & Mazzoli 1988). 
Considering our results, the use of MEIs could be an optional 
treatment for patients experiencing tinnitus with moderate to 
severe hearing loss.
Because tinnitus is related deeply to mood disorders, eval-
uations of the psychological problems associated with tinni-
tus are important. The severity of tinnitus is associated with 
psychiatric distress such as anxiety and depression in tinni-
tus patients (Crocetti et al. 2009). Cho et al. recommended 
psychological counseling for tinnitus patients, particularly if 
the patient receives a THI score in excess of 38 (classified 
as moderate or more severe suffering as a result of tinnitus) 
(Cho et al. 2013). Using the BDI and BEPSI tools, we showed 
that both MEI and CI groups showed effective postimplanta-
tion improvements in the stress, anxiety, and depression asso-
ciated with tinnitus.
TABLE 5. A comparison between MEI and CI groups in assessing 
annoyance, sleep disruption, depression, concentration, and 
tinnitus loudness and pitch
VAS Status
MEI Group CI Group
No. % No. %
Loudness*
  Improved 6 55 10 63
  Unchanged 3 27 4 25
  Worsened 2 18 2 12
Awareness†
  Improved 5 45 7 44
  Unchanged 5 45 6 38
  Worsened 1 10 3 18
Annoyance‡
  Improved 6 55 11 69
  Unchanged 4 36 4 25
  Worsened 1 9 1 6
BDI§
  Improved 8 73 14 88
  Unchanged 0 0 0 0
  Worsened 3 27 2 12
BEPSI¶
  Improved 6 55 10 62
  Unchanged 3 27 2 13
  Worsened 2 18 4 25
Fisher exact test results: *p value = 0.894, †p value = 0.773, ‡p value = 0.754, §p value = 0.332, 
¶p value = 0.614.
BDI, Beck depression inventory; BEPSI, Brief Encounter Psychosocial Instrument; MEI, 
middle ear implant; VAS, visual analog scale.
Fig. 3. The correlation between the variability in tinnitus handicap inventory (THI) scores and the variability in pure-tone audiometry (PTA) scores was not sig-
nificant. The correlation coefficient (C.C) is 0.133 (p = 0.696) in the middle ear implant (MEI) group and 0.246 (p = 0.359) in the cochlear implant (CI) group.
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CONCLUSIONS
After implantation of MEIs and CIs, improvements in tin-
nitus were observed in both groups. The results indicate that 
middle ear implantation in subjects with unilateral tinnitus 
accompanying moderate to severe hearing loss may be as ben-
eficial as cochlear implantation.
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